The Master of Science in Healthcare Decision Analysis program offers the opportunity to specialize in academic concentration tracks, preparing you for the increasingly specialized global healthcare industry.
Asia-Pacific Market Access | In-depth knowledge of Asia Pacific in-country biopharmaceutical industry, research & manufacturing capabilities, access & distribution networks, and future trends
Biopharmaceutical Marketing | Optimize product branding, value messaging, and strategic communication to key stakeholders
Business Intelligence | Acquire strategic analytical tools and apply an integrated, systematic approach to competitive intelligence gathering
Health Economics* | Produce decision-analytic models and impactful evidence to evaluate resource allocation trade-offs, demonstrate economic value, and assess impact of novel medical interventions
Managed Care | Commercial insurance tools including actuarial pricing, formulary design, utilization management, and new reimbursement models impacting coverage decisions
Policy Analysis | Analyze impacts of health reform and design organizational strategies to achieve actionable insights critical for navigating the changing policy landscape
Pricing | Solve complex pricing challenges and value determinations for new and mature products across market and payer types
Value, Access, and Reimbursement | Develop reimbursement strategies and value dossiers to support health technology assessments, global product launches, and market penetration
- 12 units
- Industry analysis capstone project within selected discipline
Concentration courses and capstone project topic are chosen in consultation with your academic advisor and program director based on career goals.
*Health Economics requires completion of a committee-reviewed health services research project and 15 units to qualify for concentration conferral
For more information, please contact our senior program administrator: